Ajaykumar C. Singh
Mumbai, MH 400012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in India.
Journal: Ecancermedicalscience
Published: October 28, 2024
PD-L1 in Oral Cavity Cancers-Audit for Tertiary Care Center in India.
Journal: Indian journal of surgical oncology
Published: April 08, 2024
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma.
Journal: Journal of the National Cancer Institute
Published: March 26, 2024
Long-Term Update of a Phase 3 Randomized Study Comparing Once-a-Week Versus Once-Every-3-Weeks Cisplatin Along With Radiation in Head and Neck Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 06, 2024
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer.
Journal: International journal of cancer
Published: January 16, 2024
Clinical Profile and Outcomes of Carcinoma Penis Patients Receiving Systemic Therapy at an Indian tertiary care Center: A Retrospective Observational Study.
Journal: Clinical genitourinary cancer
Published: December 28, 2023
Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I/II randomized study.
Journal: Medical oncology (Northwood, London, England)
Published: September 22, 2023
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.
Journal: JTO clinical and research reports
Published: June 17, 2023
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.
Journal: South Asian journal of cancer
Published: June 12, 2023
Lung cancer with dual EGFR and ALK driver alterations at baseline: a retrospective observational cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 16, 2022
ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenario.
Journal: Ecancermedicalscience
Published: February 08, 2022
Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC.
Journal: Clinical lung cancer
Published: January 19, 2022
Last Updated: 09/26/2026